Literature DB >> 8765269

Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome.

F Audibert1, S A Friedman, A Y Frangieh, B M Sibai.   

Abstract

OBJECTIVE: Our purpose was to compare the maternal outcome of pregnancies complicated by HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, partial HELLP syndrome, or severe preeclampsia. STUDY
DESIGN: In a retrospective cohort study we reviewed the maternal charts of 316 women with HELLP syndrome or severe preeclampsia managed at our perinatal center between July 1, 1992, and June 30, 1995. HELLP syndrome was strictly defined by previously published laboratory criteria. Women were divided into three groups: HELLP syndrome (n = 67), partial HELLP syndrome (one or two but not all three features of HELLP syndrome, n = 71), and severe preeclampsia (no features of HELLP syndrome, n = 178). Results were compared by chi 2 analysis and one-way analysis of variance.
RESULTS: Mean gestational ages at delivery in the HELLP, partial HELLP, and severe preeclampsia groups were, respectively, 31.7, 32.7, and 34.5 weeks (p < 0.001 between HELLP and severe preeclampsia). There was one maternal death from intracerebral hemorrhage in the HELLP group. In women with HELLP syndrome there was a higher incidence of cesarean section (p < 0.05), disseminated intravascular coagulation (p < 0.001), and need for transfusion (p < 0.001) than in the other two groups.
CONCLUSIONS: Higher incidences of maternal complications in women with HELLP syndrome stress the importance of strict criteria for the definition of HELLP syndrome. Women with partial HELLP syndrome should be studied and managed separately from women with complete HELLP syndrome.

Entities:  

Mesh:

Year:  1996        PMID: 8765269     DOI: 10.1016/s0002-9378(96)70162-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  28 in total

1.  DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia.

Authors:  Ryan Kc Yuen; Maria S Peñaherrera; Peter von Dadelszen; Deborah E McFadden; Wendy P Robinson
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

2.  Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia.

Authors:  Elisabeth Fabian; Florian Eisner; Ingrid Pabinger; Christian Viertler; Sigrid Regauer; Andreas Lueger; Peter Neumeister; Eva-Christine Weiss; Wolfgang Schöll; Uwe Lang; Florian Prüller; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2015-08-07       Impact factor: 1.704

Review 3.  Hypertension in pregnancy.

Authors:  Maryann Mugo; Gurushankar Govindarajan; L Romayne Kurukulasuriya; James R Sowers; Samy I McFarlane
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

4.  The HELLP syndrome, antiphospholipid antibodies, and syndromes.

Authors:  Ronald A Asherson; Claudio Galarza-Maldonado; Jose Sanin-Blair
Journal:  Clin Rheumatol       Date:  2007-10-03       Impact factor: 2.980

5.  Partial HELLP syndrome in pregnancy complicated by recurrent deep vein thromboses and palmar skin lesions in a patient with prothrombin gene 20210a mutation and antiphospholipid antibodies: an unusual case.

Authors:  Ronald A Asherson; Cathy Spargo; Jose A Gómez-Puerta
Journal:  Clin Rheumatol       Date:  2007-07-03       Impact factor: 2.980

6.  Pregnancy and catastrophic antiphospholipid syndrome.

Authors:  Jose A Gómez-Puerta; Jose Sanin-Blair; Claudio Galarza-Maldonado
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

7.  Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome.

Authors:  Arthur J Vaught; Eleni Gavriilaki; Nancy Hueppchen; Karin Blakemore; Xuan Yuan; Sara M Seifert; Sarah York; Robert A Brodsky
Journal:  Exp Hematol       Date:  2016-02-26       Impact factor: 3.084

8.  Helicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation.

Authors:  Simona Cardaropoli; Alessandro Rolfo; Annalisa Piazzese; Antonio Ponzetto; Tullia Todros
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

Review 9.  Immune thrombocytopenia in pregnancy.

Authors:  Evi Stavrou; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2009-12       Impact factor: 3.722

10.  Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and ≥34 Weeks' Gestation.

Authors:  Tuğba Kınay; Canan Küçük; Fulya Kayıkçıoğlu; Jale Karakaya
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.